Miljöpåverkan
Klonazepam
Miljörisk:
Användning av klonazepam har bedömts medföra försumbar risk för miljöpåverkan.
Nedbrytning:
Klonazepam är potentiellt persistent.
Bioackumulering:
Klonazepam har låg potential att bioackumuleras.
Läs mer
Detaljerad miljöinformation
Identification and characterisation
CAS number: 1622-61-3 [1]
Molecular weight: 315.7 [1]
Brand name: Iktorivil [1]
Physico-chemical properties
Aqueous solubility: <100 mg/l (20 °C) (method not specified) [1]
Dissociation constant, pKa: pKa = 1.5 [1], pKb = 10.5 [1]
Melting point: 236.5–238.5 °C (method not specified) [1]
Vapour pressure: 9.76*E–09 Pa (25 °C) QSAR
Boiling point: ND
KH: 8.6*E–13 atm*m3/mol QSAR
QSAR = QSAR-modelled (EPISuite, SPARC, ACD Solaris)
Predicted Environmental Concentration (PEC)
PEC is calculated according to the formula:
PEC (μg/L) = (A x 1'000'000'000 x (100-R)) / (365 x P x V x D x 100) = 1.5 x 10-6 x A x (100 - R) = 3.8 x 10-4 μg/L
Where:
A Sold quantity = 2.50 kg/y (total sold amount API in Sweden year 2020, data from IQVIA)
R Removal rate = 0 % Default [2]
P Population of Sweden = 10 x 106
V Volume of Wastewater = 200 l/day Default [2]
D Factor for Dilution = 10 Default [2]
Predicted No Effect Concentration (PNEC)
Ecotoxicological Studies
Green alga (Desmodesmus subspicatus): [4]
72 h ErC50 (growth rate) >240 mg/l loading rate (OECD 201)
72 h ErC50 (growth rate) >15.4 mg/l (solubility limit in algal medium, estimated) (OECD 201)
72 h NOEC = 2.46 mg/l loading rate (OECD 201)
(With respect to algal growth rate inhibition the following effects as compared to the untreated controls were observed at the respective loading rates: 240 mg/l (49%), 96 mg/l (46%), 38.4 mg/l (38%), 15.4 mg/l (34%) and 6.14 mg/l (16%). No significant effects were observed at 2.46 mg/l. Since no significant increase of toxicity occurred at concentrations >15.4 mg/l, this concentration can estimated to be the solubility limit in algal medium)
Water-flea (Daphnia magna): [5]
48 h EC50 (immobilisation) = 30.3 mg/l mean measured concentration (FDA Technical Assistance Document 4.08) (the nominal concentrations were 5.4, 9.1, 15.1, 25.2, 42.0 and 70.0 mg/l, The respective analytically determined mean measured concentrations were 4.04, 7.08, 11.7, 19.1, 31.4 and 48.8 mg/l, respectively)
Rainbow trout (Oncorhynchus mykiss): [7]
96 h LC50 >1000 mg/l (applied as an emulsion) (OECD 203)
96 h NOEC = 1000 mg/l (applied as an emulsion) (OECD 203)
Micro-organisms: [6]
NOEC (microbial growth) = 4.2 mg/l (FDA Technical Assistance Document 4.02)
(various pure cultures of bacteria, fungi, and cyanobacteria)
PNEC Derivation
The PNEC is based on the following data:
PNEC (mg/l) = lowest EC50/1000, where 1000 is the assessment factor used. An estimated solubility limit of 15400μ g/l in algal medium has been used for this calculation.
PNEC = 15400 / 1000 = 15.4 μg/l
Environmental Risk Classification (PEC/PNEC Ratio)
PEC Predicted Environmental Concentration = 0.00038 μg/L
PNEC Predicted No Effect Concentration = 15.4 μg/L
Ratio PEC/PNEC = 0.000024
PEC/PNEC = 0.00038/15.4 = 0.000024 for Clonazepam which justifies the phrase 'Use of Clonazepam has been considered to result in insignificant environmental risk.'
Degradation
Biotic Degradation
Ready biodegradability: ND
Inherent biodegradability: [7]
0% after 21 days of incubation BOD/ThOD (OECD 302 C)
Other degradation information: ND
Abiotic Degradation
Photodegradation: light sensitive [1]
Hydrolysis: ND
Clonazepam was not inherently biodegradable in a standard test. This justifies the phrase 'Clonazepam is potentially persistent.'
Bioaccumulation/Adsorption
logPOW 2.53 QSAR
logDOW 2.41 (25 °C, pH 7.4) (method not specified) [1]
KOC 283 l/kg QSAR
BCF <20 QSAR
Clonazepam has low potential for bioaccumulation.
Excretion/metabolism
The elimination half-life of Clonazepam is between 20 and 60 hours (mean 30 hours). Within 4–10 days 50–70% of are excreted in the urine and 10–30% in the faeces, almost exclusively in the form of free or conjugated metabolites. Less than 0.5% appears as unchanged clonazepam in the urine. [3]
References
-
F. Hoffmann-La Roche Ltd (2018): Safety Data Sheet for Clonazepam, 31.01.2018; https://www.roche.com/sustainability/what_we_do/for_communities_
and_environment/environment/safety_data_sheetsrow.htm. -
ECHA, European Chemicals Agency. 2008 Guidance on information requirements and chemical safety assessment. http://guidance.echa.europa.eu/docs/guidance_document/information_
requirements_en.htm. -
electronic Medicines Compendium (eMC). 2017. https://www.medicines.org.uk/emc/.
-
BMG Engineering Ltd, on behalf of F. Hoffmann-La Roche Ltd, Basel, Switzerland (2007). Clonazepam: Fresh water growth inhibition test with Desmodesmus subspicatus. BMG study no. 1226-07.
-
Toxikon Environmental Sciences, on behalf of F. Hoffmann-La Roche Ltd, Basel, Switzerland (1992). Clonazepam: Acute toxicity to the water flea Daphnia magna under static test conditions. Toxikon study no. J9108014b.
-
ABC Laboratories, Inc., on behalf of F. Hoffmann-La Roche Ltd, Basel, Switzerland (1992). Microbial inhibition with Clonazepam. ABC study no. 40067.
-
Roche internal ecotox report. 1981.